Prothena Corporation

Prothena Corporation is a leading biotechnology research company dedicated to developing innovative therapies for neurodegenerative and rare peripheral amyloid diseases. Located at 77 Sir John Rogerson's Quay, Block C, Grand Canal Docklands, Dublin, 2 D02 T804, IE, and with an additional location at 1800 Sierra Point Pkwy, Brisbane, California 94005, US, Prothena is committed to creating transformative medicines for those in critical need of new treatment options.

Prothena leverages deep insights into neurological dysfunction and the biology of misfolded proteins to develop targeted therapeutic solutions. The company's product portfolio aims to significantly impact neurodegenerative and rare peripheral amyloid diseases, enhancing the quality of life for millions worldwide. Prothena's unwavering commitment to scientific rigor and patient-centric innovation drives its success and ambitious goals.

At Prothena Corporation, the focus remains on advancing human health through pioneering biotechnology research. We are working to complete further information with the support of the company’s management, ensuring a comprehensive view of Prothena's capabilities and future direction. We invite the manager of Prothena to create a customized and exclusive company showcase and product listing on our platform.